1. |
Holthausen H, Blümcke I. Epilepsy-associated tumours: what epileptologists should know about neuropathology, terminology, and classification systems. Epileptic Disorders, 2016, 18(3): 240-251.
|
2. |
Blümcke I, Aronica E, Becker A, et al. Low-grade epilepsy-associated neuroepithelial tumours — the 2016 WHO classification. Nature Reviews Neurology, 2016, 12(12): 732-740.
|
3. |
Isler C, Erturk Cetin O, Ugurlar D, et al. Dysembryoplastic neuroepithelial tumours: clinical, radiological, pathological features and outcome. British Journal of Neurosurgery, 2018, 32(4): 436-441.
|
4. |
Slegers RJ, Blumcke I. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020. Acta Neuropathologica Communications, 2020, 8(1): 27.
|
5. |
Heiland DH, Staszewski O, Hirsch M, et al. Malignant transformation of a dysembryoplastic neuroepithelial tumor (DNET) characterized by genome-wide methylation analysis. Journal of Neuropathology & Experimental Neurology, 2016, 75(4): 358-365.
|
6. |
Luyken C, Blümcke I, Fimmers R, et al. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years. Cancer, 2004, 101(1): 146-155.
|
7. |
Dahiya S, Haydon DH, Alvarado D, et al. BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma. Acta Neuropathologica, 2013, 125(6): 901-910.
|
8. |
Zaky W, Patil SS, Park M, et al. Ganglioglioma in children and young adults: single institution experience and review of the literature. Journal of Neuro-Oncology, 2018, 139(3): 739-747.
|